مرجع دارویی
Iptacopan
Iptacopan is a medicine in the class miscellaneous. It is used for nephropathy.
- گروه دارویی: Miscellaneous
- موارد مصرف: nephropathy
آخرین بهروزرسانی منابع: US FDA label
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصهای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمیشود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
نکات کلیدی
- گروه دارویی
- Miscellaneous
- شکلهای دارویی رایج
- کپسول
- قدرتهای رایج
- 200 mg
- تداخلهای شناختهشده
- 5 (متوسط: 5)
- نامهای تجاری
- 2
- کشورها و بازارها
- 2
موارد مصرف
نحوه اثر
Iptacopan binds Factor B of the alternative complement pathway and regulates C3 cleavage, generation of downstream effectors and amplification of the terminal pathway. In PNH it controls both C3b-mediated extravascular hemolysis and terminal complement-mediated intravascular hemolysis.
دوز معمول بزرگسالان (خلاصه برچسب)
PNH, IgAN, C3G: 200 mg orally twice daily, without regard to food; swallow capsules whole
بارداری و شیردهی
- بارداری
- Unknown Human data are insufficient to show a risk; no fetal harm in rats or rabbits at 4 to 6 times human exposure. Untreated PNH or the kidney diseases it treats carry serious risks in pregnancy. US label: use may be considered after weighing risks and benefits.
- شیردهی
- Unknown No data on milk or infant effects. LactMed repeats the label advice. US label: stop breastfeeding during treatment and for 5 days after the last dose because of possible serious infant reactions (a general precaution; no specific harm is known).
عوارض جانبی گزارششده
- Headache
- Nasopharyngitis
- Diarrhea
- Abdominal pain
- Bacterial infection
- Viral infection
هشدارهای جعبه سیاه
- Complement inhibitor that increases the risk of serious, life-threatening or fatal infections caused by encapsulated bacteria (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b). Complete or update vaccination at least 2 weeks before the first dose unless delaying therapy is riskier, following ACIP recommendations. Risk persists even with vaccine antibodies. Monitor for early signs of infection and evaluate immediately. Available only through the FABHALTA REMS.
موارد منع مصرف
- Serious hypersensitivity to iptacopan or any of the excipients.
- Initiation in patients with unresolved serious infection caused by encapsulated bacteria.
چه کسانی باید احتیاط کنند
- Serious infections with encapsulated bacteria; if urgent therapy is needed in patients not up to date on vaccines, give antibacterial prophylaxis and vaccinate as soon as possible.
- Available only through the FABHALTA REMS; prescribers and pharmacies must be certified.
- PNH: after discontinuation, monitor for at least 2 weeks for signs and symptoms of hemolysis.
بارداری یا شیردهی، بیماری کلیه یا کبد، آلرژیها و هر داروی یا مکمل دیگری را که مصرف میکنید به داروساز یا پزشک خود اطلاع دهید.
مهمترین تداخلات (5)
- Carbamazepine + Iptacopan Moderate
- Gemfibrozil + Iptacopan Moderate
- Iptacopan + Phenytoin Moderate
- Iptacopan + Rifampicin Moderate
- Iptacopan + Secobarbital Moderate
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا تکنگاری کامل Iptacopan را ببینید: دوزها، بارداری و شیردهی، عوارض جانبی، هشدارها و همه تداخلها.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
پرسشهای متداول
What is Iptacopan used for?
Iptacopan is a medicine in the class miscellaneous. It is used for Nephropathy.
What side effects have been reported with Iptacopan?
Headache, Nasopharyngitis, Diarrhea, Abdominal pain, Bacterial infection, Viral infection. Serious warning: Complement inhibitor that increases the risk of serious, life-threatening or fatal infections caused by encapsulated bacteria (Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b).
Can Iptacopan be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Human data are insufficient to show a risk; no fetal harm in rats or rabbits at 4 to 6 times human exposure. Untreated PNH or the kidney diseases it treats carry serious risks in pregnancy. US label: use may be considered after weighing risks and benefits. Breastfeeding: Unknown. No data on milk or infant effects. LactMed repeats the label advice. US label: stop breastfeeding during treatment and for 5 days after the last dose because of possible serious infant reactions (a general precaution; no specific harm is known).
What does Iptacopan interact with?
MediHelp lists 5 known interactions for Iptacopan. Moderate: 5. The most serious include Carbamazepine, Gemfibrozil, Phenytoin.
تکنگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.